MET and prostate carcinoma: Indeed, most studies on the HGF/MET-mediated phosphorylation of STMN1 have not used prostate cancer cell lines, nor have they investigated in detail the regulation of both tSTMN1 and STMN1 phosphorylation during cell cycle progression.